Robeco Schweiz’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.7M Buy
190,933
+60,220
+46% +$28.9M 1.54% 21
2026
Q1
$64.2M Buy
130,713
+15,508
+13% +$8.42M 1.36% 25
2025
Q4
$66.8M Sell
115,205
-22,309
-16% -$12.6M 1.5% 23
2025
Q3
$66.7M Sell
137,514
-24,083
-15% -$11.2M 1.5% 23
2025
Q2
$65.5M Buy
161,597
+25,040
+18% +$10.5M 1.51% 23
2025
Q1
$68M Sell
136,557
-28,987
-18% -$15.7M 1.67% 20
2024
Q4
$86.1M Buy
165,544
+10,902
+7% +$5.99M 1.84% 20
2024
Q3
$95.7M Buy
154,642
+11,204
+8% +$6.63M 1.79% 21
2024
Q2
$79.3M Sell
143,438
-7,401
-5% -$4.24M 1.52% 23
2024
Q1
$87.7M Sell
150,839
-54,093
-26% -$30.4M 1.53% 23
2023
Q4
$109M Sell
204,932
-62,051
-23% -$30M 1.83% 17
2023
Q3
$135M Sell
266,983
-106,820
-29% -$56.9M 2.28% 9
2023
Q2
$195M Sell
373,803
-31,662
-8% -$17.1M 2.91% 3
2023
Q1
$234M Sell
405,465
-30,703
-7% -$17.3M 3.78% 1
2022
Q4
$240M Buy
436,168
+30,443
+8% +$16.1M 4.39% 1
2022
Q3
$0 Buy
405,725
+22,370
+6% +$12.5M ﹤0.01% 162
2022
Q2
$208M Sell
383,355
-15,940
-4% -$8.77M 3.71% 3
2022
Q1
$236M Sell
399,295
-34,544
-8% -$19.8M 3.32% 3
2021
Q4
$289M Sell
433,839
-34,747
-7% -$21.7M 3.75% 3
2021
Q3
$268K Sell
468,586
-9,081
-2% -$4.98M 3.12% 6
2021
Q2
$241M Buy
477,667
+28,501
+6% +$13.4M 3.36% 6
2021
Q1
$205M Buy
449,166
+115,638
+35% +$55.2M 3.13% 6
2020
Q4
$155M Buy
333,528
+55,929
+20% +$26.2M 3.33% 4
2020
Q3
$123M Sell
277,599
-33,278
-11% -$13.7M 3.63% 2
2020
Q2
$113M Sell
310,877
-24,462
-7% -$8.2M 4.04% 3
2020
Q1
$95.6M Sell
335,339
-61,495
-15% -$19.4M 4.09% 2
2019
Q4
$129M Buy
396,834
+48,462
+14% +$14.7M 4.81% 1
2019
Q3
$100M Sell
348,372
-13,786
-4% -$3.95M 4.3% 1
2019
Q2
$106M Sell
362,158
-8,859
-2% -$2.44M 4.51% 1
2019
Q1
$102M Sell
371,017
-62,336
-14% -$15.5M 4.2% 1
2018
Q4
$96.4M Sell
433,353
-2,611
-0.6% -$613K 4.46% 1
2018
Q3
$107M Sell
435,964
-21,856
-5% -$5.03M 4.16% 1
2018
Q2
$94.1M Sell
457,820
-16,657
-4% -$3.54M 4.01% 1
2018
Q1
$98M Sell
474,477
-12,771
-3% -$2.68M 4.54% 1
2017
Q4
$93.1M Sell
487,248
-11,010
-2% -$2.11M 6.15% 1
2017
Q3
$92.9M Buy
498,258
+155,641
+45% +$28.2M 7.16% 1
2017
Q2
$59.6M Sell
342,617
-8,654
-2% -$1.45M 5% 1
2017
Q1
$54.1M Sell
351,271
-28,320
-7% -$4.33M 4.61% 1
2016
Q4
$53.7M Sell
379,591
-27,174
-7% -$4.01M 4.94% 1
2016
Q3
$63.5M Sell
406,765
-18,760
-4% -$2.89M 5.51% 1
2016
Q2
$61.8M Buy
425,525
+82,871
+24% +$12.2M 5.66% 1
2016
Q1
$48.2M Sell
342,654
-28,690
-8% -$3.84M 4.63% 1
2015
Q4
$53M Buy
371,344
+9,345
+3% +$1.25M 4.54% 1
2015
Q3
$43.4M Buy
361,999
+40,155
+12% +$5.23M 4.05% 1
2015
Q2
$41.7M Sell
321,844
-17,549
-5% -$2.29M 3.46% 3
2015
Q1
$46M Buy
339,393
+11,632
+4% +$1.5M 3.61% 3
2014
Q4
$41.5M Sell
327,761
-164,359
-33% -$20M 3.16% 3
2014
Q3
$60M Buy
492,120
+110,861
+29% +$13.5M 4.8% 1
2014
Q2
$45.1M Buy
381,259
+72,670
+24% +$8.55M 3.68% 3
2014
Q1
$36.6M Sell
308,589
-131,929
-30% -$15.7M 3.17% 5
2013
Q4
$48.7M Sell
440,518
-94,032
-18% -$9.35M 4.31% 3
2013
Q3
$49.7M Sell
534,550
-148,371
-22% -$13.4M 4.17% 2
2013
Q2
$58.3M Buy
+682,921
New +$56.8M 5.24% 2

Other funds holding TMO

Robeco Schweiz's TMO Position: Q2 2026 in Review

Robeco Schweiz increased its Thermo Fisher Scientific (TMO) stake by 46% in Q2 2026, buying an estimated $28.9M and bringing the position to 190,933 shares worth $95.7M. The position accounts for 1.54% of the portfolio, ranked #21.

Robeco Schweiz first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $289M in Q4 2021. 1,030 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Robeco Schweiz held 190,933 shares of Thermo Fisher Scientific worth $95.7M as of Q2 2026.
  • Robeco Schweiz bought 60,220 Thermo Fisher Scientific shares in Q2 2026, an estimated $28.9M.
  • Thermo Fisher Scientific made up 1.54% of Robeco Schweiz's portfolio in Q2 2026, its #21 holding.
  • Robeco Schweiz first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Robeco Schweiz's Thermo Fisher Scientific position peaked at $289M in Q4 2021.
  • 1,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Robeco Schweiz's 13F filing for Q2 2026, filed 28 Jul 2026.